Cerebrovascular Reactivity
Learn how Transcranial Doppler (TCD) ultrasound enables non-invasive, real-time cerebrovascular reactivity (CVR) assessment for stroke risk prediction, TBI monitoring, and dementia evaluation. Discover NeuraSignal’s automated TCD technology.
What Is Cerebrovascular Reactivity (CVR)?
Cerebrovascular reactivity (CVR) — also called vasomotor reactivity (VMR) — is the ability of cerebral blood vessels to dilate or constrict in response to metabolic stimuli such as changes in arterial carbon dioxide (CO₂) levels. It is a critical measure of the brain’s capacity to regulate blood flow and maintain adequate perfusion under varying conditions. 1 2
Impaired CVR is an independent risk factor for ischemic events and is increasingly recognized as a biomarker of brain health, with prognostic value for stroke risk and cognitive decline. 3 4 5
Transcranial Doppler (TCD) for Non-Invasive CVR Assessments
First described by Aaslid and colleagues in 1982, Transcranial Doppler (TCD) ultrasound is a non-invasive method for evaluating cerebral blood flow by measuring flow velocities in the basal arteries of the brain. 6 TCD has since become one of the most commonly utilized methods for intracranial monitoring in critically ill patients and the most popular non-invasive cerebral monitoring modality. 6
TCD allows real-time, continuous, and bilateral recording of cerebral blood flow velocity through major arteries — particularly the middle cerebral artery (MCA). It is inexpensive, portable, and well-tolerated, even by aged and cognitively impaired individuals. 7
How CVR Is Measured with TCD
CVR assessment using TCD involves measuring changes in MCA blood flow velocity in response to a vasodilatory or vasoconstrictive stimulus:
CO₂ inhalation (hypercapnia): Breathing a mixture of CO₂ and O₂ to induce vasodilation. This method has demonstrated the highest reproducibility for CVR assessment. 8
Breath-Holding Test (BHT): A simple, well-tolerated bedside method where the patient holds their breath for ~30 seconds, causing endogenous CO₂ buildup. The resulting change in MCA velocity is expressed as the Breath-Holding Index (BHI). 2 9
Hyperventilation (hypocapnia): Voluntary hyperventilation to reduce CO₂ and induce vasoconstriction, testing the vasoconstrictive reserve. 8
Acetazolamide administration: An IV pharmacological vasodilatory stimulus. 2
Post-stenotic waveform patterns (delayed systolic acceleration) in segments distal to the narrowing
The BHI has recently emerged as the most accurate and robust metric of CVR for predicting mild cognitive disorders, with an AUC of 0.827. 10
Clinical Applications
CO₂ inhalation (hypercapnia): Breathing a mixture of CO₂ and O₂ to induce vasodilation. This method has demonstrated the highest reproducibility for CVR assessment. 8
Disruption of cerebrovascular reactivity following TBI has been known since the 1970s. TCD-based continuous time-domain indices of CVR (such as the mean flow index, Mx) have demonstrated significant prognostic utility for functional outcomes following TBI. Recent studies indicate that systolic flow velocity-based indices may contain the most prognostic value. 6
VMR is significantly reduced in patients with Alzheimer's disease compared to age-matched controls — 24.5% vs. 36.6% on the right MCA and 20.7% vs. 34.1% on the left MCA (p<0.05). 11 Reduced cerebrovascular reactivity has been shown to predict cognitive decline in AD patients, and the pulsatility index and presence of spontaneous emboli detected via TCD are among the best discriminators of dementia from normal aging. 7
CVR assessed by BHI has also been identified as a significant predictor of conversion from mild cognitive impairment (MCI) to dementia. 5 10
In subarachnoid hemorrhage (SAH) and TBI, TCD-based CVR monitoring helps assess delayed cerebral ischemia risk and guides interventions such as induced hypertension or vasodilatory therapy. 6
Book a Live Demo
Let's Get started
Discover the future of automated Transcranial Doppler technology. Schedule a brief demo with our specialists to see how non-invasive, robotic TCD fits into your hospital’s workflow.
With real-time information, clinical teams can make more informed decisions about patient management, leading to reduced length of stay and improving patient outcomes.
With the NeuraSignal Platform, healthcare professionals can detect and manage complications more quickly, helping to prevent adverse outcomes, reduce hospital readmissions, and ultimately leading to better patient satisfaction.
References
- Herrera Campos CR, et al. “Cerebral vasomotor reactivity assessment using Transcranial Doppler and MRI with apnea test.” Braz J Med Biol Res. 2016;49(11):e5437. PMC Full Text
- Markus HS, Harrison MJG. “Assessment of cerebral vasomotor reactivity by transcranial Doppler ultrasound and breath-holding.” Stroke. 1995;26(1):96. AHA Journals
- Markus H, Cullinane M. “Severely impaired cerebrovascular reactivity predicts stroke and TIA risk in patients with carotid artery stenosis and occlusion.” Brain. 2001;124(3):457–467. Oxford Academic
- Silvestrini M, et al. “Transcranial Doppler assessment of cerebrovascular reactivity in symptomatic and asymptomatic severe carotid stenosis.” Stroke. 1996;27(11):1970–1973. PubMed
- Silvestrini M, et al. “Cerebrovascular Reactivity and Cognitive Decline in Patients With Alzheimer Disease.” Stroke. 2006. AHA Journals
- Gomez A, et al. “Transcranial Doppler Based Cerebrovascular Reactivity Indices in Adult Traumatic Brain Injury: A Scoping Review.” Front. Pharmacol. 2021;12:690921. Frontiers
- Keage HAD, et al. “Cerebrovascular Function in Aging and Dementia: A Systematic Review of Transcranial Doppler Studies.” Dement Geriatr Cogn Dis Extra. 2012;2(1):258–270. PMC Full Text
- Totaro R, et al. “Cerebrovascular reactivity evaluated by transcranial Doppler: reproducibility of different methods.” Cerebrovasc Dis. 1999;9(3):142–145. PubMed
- Burley CV, et al. “Contrasting Measures of Cerebrovascular Reactivity Between MRI and Doppler.” Front. Physiol. 2021;12:656746. Frontiers
- Ackah JA, et al. “Cerebrovascular reactivity metrics as predictors of cognitive performance in healthy ageing.” Ultrasound J. 2025;17:49. PMC Full Text
- Lee ST, et al. “Decreased Vasomotor Reactivity in Alzheimer’s Disease.” J Clin Neurol. 2007;3(1):18–23. PMC Full Text
Disclaimer of Information & Content
The information provided on the NeuraSignal website is intended for educational and informational purposes only and should not be construed as medical advice, a diagnostic opinion, or a guarantee of clinical outcome. While NeuraSignal strives to present accurate and up-to-date information sourced from peer-reviewed literature and reputable clinical references, NeuraSignal makes no representations or warranties regarding the completeness, accuracy, reliability, or timeliness of any content presented herein. No individual, including patients currently under clinical evaluation, should rely on the information, tools, or resources available on this website for self-diagnosis, self-treatment, or as a substitute for professional medical consultation. Clinical decisions should always be made in partnership with a qualified healthcare provider. NeuraSignal expressly disclaims any liability arising from the use or interpretation of the content on this website.